Suppr超能文献

糖基磷脂酰肌醇(GPI)锚定的 NKG2D 配体脱落的差异机制。

Differential mechanisms of shedding of the glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands.

机构信息

Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, United Kingdom.

出版信息

J Biol Chem. 2010 Mar 19;285(12):8543-51. doi: 10.1074/jbc.M109.045906. Epub 2010 Jan 14.

Abstract

Tumor cells release NKG2D ligands to evade NKG2D-mediated immune surveillance. The purpose of our investigation was to explore the cellular mechanisms of release used by various members of the ULBP family. Using biochemical and cellular approaches in both transfectant systems and tumor cell lines, this paper shows that ULBP1, ULBP2, and ULBP3 are released from cells with different kinetics and by distinct mechanisms. Whereas ULBP2 is mainly shed by metalloproteases, ULBP3 is abundantly released as part of membrane vesicles known as exosomes. Interestingly, exosomal ULBP3 protein is much more potent for down-modulation of the NKG2D receptor than soluble ULBP2 protein. This is the first report showing functionally relevant differences in the biochemistry of the three members of the ULBP family and confirms that in depth study of the biochemical features of individual NKG2D ligands will be necessary to understand and manipulate the biology of these proteins for therapy.

摘要

肿瘤细胞释放 NKG2D 配体以逃避 NKG2D 介导的免疫监视。我们研究的目的是探索 ULBP 家族各成员所使用的细胞释放机制。本文通过转染系统和肿瘤细胞系中的生化和细胞方法,表明 ULBP1、ULBP2 和 ULBP3 以不同的动力学和不同的机制从细胞中释放。虽然 ULBP2 主要通过金属蛋白酶脱落,但 ULBP3 作为称为外泌体的膜囊泡的一部分大量释放。有趣的是,外泌体 ULBP3 蛋白对 NKG2D 受体的下调作用比可溶性 ULBP2 蛋白强得多。这是首次报道 ULBP 家族的三个成员在生物化学方面存在功能相关的差异,并证实深入研究单个 NKG2D 配体的生化特征对于理解和操纵这些蛋白质的生物学特性以进行治疗是必要的。

相似文献

4
Natural killer cell-mediated shedding of ULBP2.自然杀伤细胞介导的ULBP2脱落
PLoS One. 2014 Mar 10;9(3):e91133. doi: 10.1371/journal.pone.0091133. eCollection 2014.
9
[Effects of matrine on the expression of NKG2D ligands in leukemia cells].[苦参碱对白血病细胞中NKG2D配体表达的影响]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Dec;21(6):1429-34. doi: 10.7534/j.issn.1009-2137.2013.06.012.

引用本文的文献

2
Tumor-Expressed SPPL3 Supports Innate Antitumor Immune Responses.肿瘤表达的SPPL3支持先天性抗肿瘤免疫反应。
Eur J Immunol. 2025 Feb;55(2):e202451129. doi: 10.1002/eji.202451129. Epub 2024 Dec 10.

本文引用的文献

5
NKG2D ligands in tumor immunity.肿瘤免疫中的NKG2D配体
Oncogene. 2008 Oct 6;27(45):5944-58. doi: 10.1038/onc.2008.272.
6
Tumor-associated MICA is shed by ADAM proteases.肿瘤相关的MICA可被ADAM蛋白酶切割释放。
Cancer Res. 2008 Aug 1;68(15):6368-76. doi: 10.1158/0008-5472.CAN-07-6768.
8
Human tumor-derived exosomes down-modulate NKG2D expression.人肿瘤来源的外泌体下调NKG2D表达。
J Immunol. 2008 Jun 1;180(11):7249-58. doi: 10.4049/jimmunol.180.11.7249.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验